Design a process for pharmaceutical regulatory affairs that clinical staff can follow without obstructing care.
Managing Regulatory Affairs for Pharmaceutical Preparations
A practical programme in pharmaceutical regulatory affairs for professionals who are accountable for results, not just awareness.
📍 Tripoli🗓️ 5 training days📚 4 modules🎓 Accredited certificate
5intensive training days
4scientific modules
8training sessions
32detailed points
Course Overview
Cost pressure and quality expectations on pharmaceutical regulatory affairs are rising at the same time. In healthcare, a weakness in this area of health and pharmaceutical services is eventually paid for by a patient. The level assumes working familiarity with the clinical service but no prior formal training in the health and pharmaceutical services discipline. Content is organised around the decisions practitioners actually face in pharmaceutical regulatory affairs, not around theory headings. Participants apply this strand of health and pharmaceutical services to their own clinical service throughout, so the output is directly usable. The course leaves participants able to diagnose weaknesses in the practice within health and pharmaceutical services before they become incidents. Progress on pharmaceutical regulatory affairs is usually lost in the gap between approval and execution. The most reliable predictor of sound this aspect of health and pharmaceutical services is whether anyone reviews it when nothing has gone wrong. The final module sets out how progress on the practice within health and pharmaceutical services will be evidenced six months later.
Expected Learning Outcomes
Translate policy on pharmaceutical regulatory affairs into procedures that hold up under day-to-day pressure.
Apply root cause analysis to adverse events involving pharmaceutical regulatory affairs.
Control cost per episode within pharmaceutical regulatory affairs without shifting risk to patients.
Apply a repeatable review cycle to pharmaceutical regulatory affairs and act on what it produces.
Design escalation for clinical deterioration detected through pharmaceutical regulatory affairs.
Assess the current state of pharmaceutical regulatory affairs against a structured set of criteria rather than impressions.
Who Should Attend
Finance managers costing services delivered through pharmaceutical regulatory affairs.
Accreditation and compliance officers preparing evidence on pharmaceutical regulatory affairs.
Anyone whose accountability for pharmaceutical regulatory affairs exceeds their current formal training in it.
Consultants and advisers supporting clients on pharmaceutical regulatory affairs.
Health information and records staff supporting pharmaceutical regulatory affairs.
Infection prevention and control practitioners covering pharmaceutical regulatory affairs.
Course Modules
Pharmaceutical regulatory affairs: regulation, licensing and accreditation evidence
2 sessions · 8 pointsSession 1Choosing indicators for pharmaceutical regulatory affairs that reflect outcome
- Map the handovers in pharmaceutical regulatory affairs between functions and secure them.
- Draft the minimum viable clinical protocol for pharmaceutical regulatory affairs.
- Build medication safety checks into pharmaceutical regulatory affairs at the point of highest risk.
- Check that consent processes within pharmaceutical regulatory affairs are genuinely informed.
Session 2What to measure in pharmaceutical regulatory affairs and what to ignore
- Rank the weaknesses in pharmaceutical regulatory affairs by consequence rather than by ease of fixing.
- Measure patient experience of pharmaceutical regulatory affairs and feed it back to the team.
- Define acceptance criteria for pharmaceutical regulatory affairs in advance.
- Confirm licensing and regulatory requirements applying to pharmaceutical regulatory affairs are met.
Pharmaceutical regulatory affairs: quality indicators and patient outcome
2 sessions · 8 pointsSession 1Designing pharmaceutical regulatory affairs so it helps rather than obstructs care
- Confirm patient data handled within pharmaceutical regulatory affairs meets confidentiality obligations.
- Confirm the incident reporting route for pharmaceutical regulatory affairs is quick and non-punitive.
- Close the loop: confirm changes to pharmaceutical regulatory affairs improved the indicator they targeted.
- Assign responsibility for keeping documentation of pharmaceutical regulatory affairs current.
Session 2Keeping supply and cold chain reliable for pharmaceutical regulatory affairs
- Plan the sequence in which improvements to pharmaceutical regulatory affairs will be introduced.
- Apply structured root cause analysis to the last adverse event involving pharmaceutical regulatory affairs.
- Set the review interval for pharmaceutical regulatory affairs and who attends.
- Audit pharmaceutical regulatory affairs by observing practice, not by reading policy.
Pharmaceutical regulatory affairs: cost, efficiency and sustainability of the service
2 sessions · 8 pointsSession 1Comparing pharmaceutical regulatory affairs with recognised practice
- Compare the cost of pharmaceutical regulatory affairs with the cost of its absence.
- Match staffing levels on pharmaceutical regulatory affairs to measured demand across the week.
- Assemble the accreditation evidence pack for pharmaceutical regulatory affairs.
- Write down the assumptions underpinning the approach to pharmaceutical regulatory affairs.
Session 2Making incident reporting on pharmaceutical regulatory affairs safe for staff
- Decide what will be stopped to create capacity for pharmaceutical regulatory affairs.
- Identify the data already collected that bears on pharmaceutical regulatory affairs.
- Select quality indicators for pharmaceutical regulatory affairs that measure outcome rather than activity.
- Define escalation criteria for deterioration detected through pharmaceutical regulatory affairs.
Pharmaceutical regulatory affairs: confidentiality, consent and ethics
2 sessions · 8 pointsSession 1Escalation and decision rights in pharmaceutical regulatory affairs
- Cost pharmaceutical regulatory affairs per episode and identify avoidable waste.
- Identify single points of dependency in pharmaceutical regulatory affairs and reduce them.
- Name a single owner for each element of pharmaceutical regulatory affairs.
- Confirm that reporting on pharmaceutical regulatory affairs reaches the people who can act.
Session 2Infection risk created by pharmaceutical regulatory affairs
- Verify cold chain and storage conditions for materials used in pharmaceutical regulatory affairs.
- Check that pharmaceutical regulatory affairs still works when volumes rise unexpectedly.
- Anticipate the objections pharmaceutical regulatory affairs will raise and prepare the answers.
- Map the clinical workflow for pharmaceutical regulatory affairs as it is actually performed.
Choose the package that suits you
Silver Package
At least 3 people
USD1,250
- Workshop or Program Participation
- Airport Transfers
- Customized Badge
- Expert Mentorship (Private Sessions)
- Supervision & Secretarial Services
- Accredited Certificate of Participation
- Complete Training Kit
- Coffee Break
- Closing Ceremony
Gold Package
At least 3 people
USD1,850
- 5-night stay in a 5-star hotel
- Workshop or Program Participation
- Airport Transfers
- Customized Badge
- Expert Mentorship (Private Sessions)
- Supervision & Secretarial Services
- Accredited Certificate of Participation
- Complete Training Kit
- Coffee Break
- Closing Ceremony
Complete your registration
We will contact you within one business day to confirm.